Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    April 2020
  1. ISAIA G, Marinello R, Tibaldi V, Tamone C, et al
    Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.
    Am J Geriatr Psychiatry. 2020 Apr 22. pii: S1064-7481(20)30319.
    PubMed    


  2. BROWN EE, Kumar S, Rajji TK, Pollock BG, et al
    Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2020 Apr 18. pii: S1064-7481(20)30294.
    PubMed     Abstract available


  3. BEAUDREAU SA, Schneider L
    Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum".
    Am J Geriatr Psychiatry. 2020 Apr 15. pii: S1064-7481(20)30291.
    PubMed    


  4. ALMEIDA OP, Ford AH
    Are We Getting Better at Managing Agitation in Dementia?
    Am J Geriatr Psychiatry. 2020;28:401-403.
    PubMed    


    March 2020
  5. CHEN CL, Liang CK, Yin CH, Lin YT, et al
    Corrigendum to 'Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan' [The American Journal of Geriatric Psychiatry 28 (2020) 205-216].
    Am J Geriatr Psychiatry. 2020 Mar 17. pii: S1064-7481(20)30256.
    PubMed    


    February 2020
  6. BANNING LCP, Ramakers IHGB, Kohler S, Bron EE, et al
    The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Am J Geriatr Psychiatry. 2020 Feb 19. pii: S1064-7481(20)30025.
    PubMed     Abstract available


    October 2019
  7. FORESTER BP, Rahman AT, Harper DG, Petrides G, et al
    Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Oct 24. pii: S1064-7481(19)30548.
    PubMed    


  8. GROSSBERG GT, Kohegyi E, Mergel V, Josiassen MK, et al
    Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
    Am J Geriatr Psychiatry. 2019 Oct 1. pii: S1064-7481(19)30521.
    PubMed     Abstract available


    August 2019
  9. RANDOLPH C
    The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Aug 19. pii: S1064-7481(19)30475.
    PubMed     Abstract available


  10. NOVAK P, Chu J, Ali MM, Chen J, et al
    Racial and Ethnic Disparities in Serious Psychological Distress Among Those With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2019 Aug 15. pii: S1064-7481(19)30473.
    PubMed     Abstract available


  11. CHAPMAN BP, Phillips C
    Financial Risk Aversion and Incipient Dementia.
    Am J Geriatr Psychiatry. 2019;27:862-864.
    PubMed    


    July 2019
  12. CHANG MC, Lee AY, Kwak S, Kwak SG, et al
    Effect of Resistance Exercise on Depression in Mild Alzheimer Disease Patients With Sarcopenia.
    Am J Geriatr Psychiatry. 2019 Jul 27. pii: S1064-7481(19)30458.
    PubMed    


  13. PRASAD KM
    Digging Deeper Into Delusion Circuitry in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 Jul 3. pii: S1064-7481(19)30425.
    PubMed    


    June 2019
  14. CHEN NC, Liang CK, Yin CH, Lin YT, et al
    Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan.
    Am J Geriatr Psychiatry. 2019 Jun 24. pii: S1064-7481(19)30417.
    PubMed     Abstract available


  15. VYAS CM, Okereke OI
    Vitamin D and Psychosis in Alzheimer Disease: New Insights From Pharmacogenomics Research.
    Am J Geriatr Psychiatry. 2019 Jun 4. pii: S1064-7481(19)30392.
    PubMed    


    May 2019
  16. POLLOCK BG
    Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
    Am J Geriatr Psychiatry. 2019 May 27. pii: S1064-7481(19)30387.
    PubMed    


  17. ROSENBERG PB, Outen M S JD, Amjad M D M P H H, Burhanullah M D MH, et al
    Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 24. pii: S1064-7481(19)30370.
    PubMed    


  18. PARADISE DM
    Commentary on: Mechanisms Linking White Matter Lesions, Tract Integrity and Depression in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30365.
    PubMed    


  19. KRIVINKO JM, Koppel J, Savonenko A, Sweet RA, et al
    Animal Models of Psychosis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30364.
    PubMed     Abstract available


  20. AGA VM
    When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
    Am J Geriatr Psychiatry. 2019 May 10. pii: S1064-7481(19)30350.
    PubMed     Abstract available


  21. HERRMANN N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, et al
    Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 8. pii: S1064-7481(19)30355.
    PubMed     Abstract available


    April 2019
  22. YATAWARA C, Lee D, Ng KP, Chander R, et al
    Mechanisms Linking White Matter Lesions, Tract Integrity, and Depression in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Apr 18. pii: S1064-7481(19)30337.
    PubMed     Abstract available


  23. SCHULZ R
    The Future of Caregiver Efficacy Research: Commentary on "Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers".
    Am J Geriatr Psychiatry. 2019 Apr 10. pii: S1064-7481(19)30334.
    PubMed    


  24. QIAN W, Fischer CE, Churchill NW, Kumar S, et al
    Delusions in Alzheimer Disease are Associated With Decreased Default Mode Network Functional Connectivity.
    Am J Geriatr Psychiatry. 2019 Apr 3. pii: S1064-7481(19)30331.
    PubMed     Abstract available


  25. VERMA M
    Reliably Assessing Language Function in Dementia in the 21st Century.
    Am J Geriatr Psychiatry. 2019;27:378-380.
    PubMed    


  26. STARKSTEIN S, Hayhow B
    Apathy in Dementia: Time to StandUp.
    Am J Geriatr Psychiatry. 2019;27:406-407.
    PubMed    


    March 2019
  27. WANG L, Ying J, Fan P, Weamer EA, et al
    Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.
    Am J Geriatr Psychiatry. 2019 Mar 27. pii: S1064-7481(19)30321.
    PubMed     Abstract available


  28. CHENG ST, Chan WC, Lam LCW
    Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial.
    Am J Geriatr Psychiatry. 2019 Mar 26. pii: S1064-7481(19)30305.
    PubMed     Abstract available


  29. PATRICK RE, Hobbs K, Mathias L, Harper DG, et al
    The Limitations of Using Cognitive Cutoff Scores for Enrollment in Alzheimer Trials.
    Am J Geriatr Psychiatry. 2019 Mar 1. pii: S1064-7481(19)30275.
    PubMed    


  30. FUJISHIRO H
    Late-Life Depression and Lewy Body Disease.
    Am J Geriatr Psychiatry. 2019;27:287-289.
    PubMed    


    February 2019
  31. WILSON RS, Yu L, Schneider JA, Bennett DA, et al
    Risk Aversion and Alzheimer Disease in Old Age.
    Am J Geriatr Psychiatry. 2019 Feb 21. pii: S1064-7481(19)30253.
    PubMed     Abstract available


  32. RUTHIRAKUHAN M, Herrmann N, Vieira D, Gallagher D, et al
    The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment.
    Am J Geriatr Psychiatry. 2019 Feb 7. pii: S1064-7481(19)30242.
    PubMed     Abstract available


    January 2019
  33. PRASAD KM
    Delusions in Alzheimer Disease: What Researchers Should Not Forget.
    Am J Geriatr Psychiatry. 2019 Jan 9. pii: S1064-7481(19)30008.
    PubMed    


    December 2018
  34. ZHU CW, Grossman HT, Sano M
    Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Dec 17. pii: S1064-7481(18)30599.
    PubMed     Abstract available


    October 2018
  35. YU R, Topiwala A, Jacoby R, Fazel S, et al
    Aggressive Behaviors in Alzheimer Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2018 Oct 19. pii: S1064-7481(18)30529.
    PubMed     Abstract available


  36. QIAN W, Schweizer TA, Churchill NW, Millikin C, et al
    Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Oct 2. pii: S1064-7481(18)30499.
    PubMed     Abstract available


    September 2018
  37. BOTT NT, Sheckter CC, Yang D, Peters S, et al
    Systems Delivery Innovation for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Sep 28. pii: S1064-7481(18)30494.
    PubMed     Abstract available


  38. LINCOLN KD, Chow TW, Gaines BF
    BrainWorks: A Comparative Effectiveness Trial to Examine Alzheimer's Disease Education for Community-Dwelling African Americans.
    Am J Geriatr Psychiatry. 2018 Sep 21. pii: S1064-7481(18)30487.
    PubMed     Abstract available


    June 2018
  39. DEVANAND DP, Pelton GH, D'Antonio K, Ciarleglio A, et al
    Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2018 Jun 28. pii: S1064-7481(18)30333.
    PubMed     Abstract available


    May 2018
  40. GALLAGHER D, Kiss A, Lanctot K, Herrmann N, et al
    Depression and Risk of Alzheimer's Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression.
    Am J Geriatr Psychiatry. 2018 May 9. pii: S1064-7481(18)30327.
    PubMed     Abstract available


  41. MUNRO CE, Donovan NJ, Amariglio RE, Papp KV, et al
    The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.
    Am J Geriatr Psychiatry. 2018 May 3. pii: S1064-7481(18)30323.
    PubMed     Abstract available


    April 2018
  42. WOODWARD MR, Hafeez MU, Qi Q, Riaz A, et al
    Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.
    Am J Geriatr Psychiatry. 2018 Apr 19. pii: S1064-7481(18)30247.
    PubMed     Abstract available


    October 2017
  43. CONNORS MH, Ames D, Woodward M, Brodaty H, et al
    Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Am J Geriatr Psychiatry. 2017 Oct 20. pii: S1064-7481(17)30512.
    PubMed     Abstract available


    September 2017
  44. HUGHES TM, Lockhart SN, Smagula SF
    Blood Pressure's Role in Alzheimer Disease Pathology.
    Am J Geriatr Psychiatry. 2017 Sep 25. pii: S1064-7481(17)30468.
    PubMed    


    July 2017
  45. YOSHIDA K, Roberts R, Suzuki T, Lebowitz B, et al
    Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
    Am J Geriatr Psychiatry. 2017;25:708-716.
    PubMed     Abstract available


    June 2017
  46. ERSKINE D, Thomas AJ, Taylor JP, Savage MA, et al
    Neuronal Loss and Alpha-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.
    Am J Geriatr Psychiatry. 2017;25:595-604.
    PubMed     Abstract available


    April 2017
  47. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
    Am J Geriatr Psychiatry. 2017 Apr 25. pii: S1064-7481(17)30306.
    PubMed     Abstract available


    March 2017
  48. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed    


  49. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed    


    February 2017
  50. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Abstract available


    January 2017
  51. WEISSBERGER GH, Melrose RJ, Narvaez TA, Harwood D, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 31. pii: S1064-7481(17)30034.
    PubMed     Abstract available


  52. SMITH GS
    Molecular Imaging of the Nicotinic Cholinergic Receptor in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 5. pii: S1064-7481(17)30001.
    PubMed    


  53. SULTZER DL, Melrose RJ, Riskin-Jones H, Narvaez TA, et al
    Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30305.
    PubMed     Abstract available


  54. GATCHEL JR, Donovan NJ, Locascio JJ, Becker JA, et al
    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30348.
    PubMed     Abstract available


    November 2016
  55. KERNER NA, Roose SP, Pelton GH, Ciarleglio A, et al
    Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.
    Am J Geriatr Psychiatry. 2016 Nov 17. pii: S1064-7481(16)30303.
    PubMed     Abstract available


  56. REGAN B, Wells Y, Farrow M, O'Halloran P, et al
    MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Nov 16. pii: S1064-7481(16)30302.
    PubMed     Abstract available


    October 2016
  57. LIN A, Brook J, Grill JD, Teng E, et al
    Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Oct 13. pii: S1064-7481(16)30273.
    PubMed     Abstract available


    August 2016
  58. ANTONSDOTTIR IM, Makino KM, Porsteinsson AP
    Dazed and Confused: Medical Cannabis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Aug 31. pii: S1064-7481(16)30222.
    PubMed    


    July 2016
  59. ROY S, Ficarro S, Duberstein P, Chapman BP, et al
    Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Jul 4. pii: S1064-7481(16)30165.
    PubMed     Abstract available


    February 2016
  60. CHOI HJ, Seo EH, Yi D, Sohn BK, et al
    Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Am J Geriatr Psychiatry. 2016;24:144-53.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: